|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 32.48 USD | -1.93% |
|
+11.35% | +32.09% |
| 01-08 | Asian Equities Traded in the US as American Depositary Receipts Rise in Thursday Trading | MT |
| 01-05 | JPMorgan Chase's long position in Bilibili decreases to 16.23% on Dec 30, HKEX filing shows | RE |
| Fiscal Period: December | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
Profitability | ||||||||||
Return on Assets | -9.97 | -10.59 | -10.67 | -8.44 | -2.55 | |||||
Return on Total Capital | -14.11 | -13.96 | -13.88 | -11.92 | -4.07 | |||||
Return On Equity % | -39.61 | -46.16 | -40.63 | -32.46 | -9.57 | |||||
Return on Common Equity | -41.11 | -46.34 | -40.59 | -32.55 | -9.45 | |||||
Margin Analysis | ||||||||||
Gross Profit Margin % | 23.67 | 20.86 | 17.58 | 24.16 | 32.7 | |||||
SG&A Margin | 37.24 | 39.38 | 32.42 | 26.8 | 23.97 | |||||
EBITDA Margin % | -11.83 | -20.57 | -21.37 | -10.36 | 3.66 | |||||
EBITA Margin % | -14.55 | -23.35 | -24.82 | -13.59 | 1.6 | |||||
EBIT Margin % | -26.18 | -33.17 | -36.61 | -22.48 | -5.01 | |||||
Income From Continuing Operations Margin % | -25.45 | -35.13 | -34.28 | -21.36 | -5.08 | |||||
Net Income Margin % | -25.1 | -35.03 | -34.23 | -21.41 | -5.02 | |||||
Net Avail. For Common Margin % | -25.1 | -35.03 | -34.23 | -21.41 | -5.02 | |||||
Normalized Net Income Margin | -15.28 | -20.92 | -22.35 | -12.78 | -2.01 | |||||
Levered Free Cash Flow Margin | 1.79 | -19.99 | -10.88 | 4.13 | 15.02 | |||||
Unlevered Free Cash Flow Margin | 2.19 | -19.62 | -10.38 | 4.49 | 15.19 | |||||
Asset Turnover | ||||||||||
Asset Turnover | 0.61 | 0.51 | 0.47 | 0.6 | 0.81 | |||||
Fixed Assets Turnover | 18.78 | 18.35 | 16.99 | 23.2 | 41.15 | |||||
Receivables Turnover (Average Receivables) | 13.34 | 15.91 | 16.16 | 15.52 | 19.16 | |||||
Inventory Turnover (Average Inventory) | 70.74 | 42 | 33.91 | 45.26 | 67.41 | |||||
Short Term Liquidity | ||||||||||
Current Ratio | 2.13 | 3.02 | 1.43 | 1.03 | 1.34 | |||||
Quick Ratio | 1.9 | 2.63 | 1.25 | 0.94 | 1.23 | |||||
Operating Cash Flow to Current Liabilities | 0.1 | -0.22 | -0.23 | 0.01 | 0.41 | |||||
Days Sales Outstanding (Average Receivables) | 27.43 | 22.93 | 22.59 | 23.51 | 19.1 | |||||
Days Outstanding Inventory (Average Inventory) | 5.17 | 8.69 | 10.76 | 8.06 | 5.43 | |||||
Average Days Payable Outstanding | 98.39 | 86.37 | 87.66 | 93.63 | 92.35 | |||||
Cash Conversion Cycle (Average Days) | -65.78 | -54.74 | -54.31 | -62.05 | -67.82 | |||||
Long Term Solvency | ||||||||||
Total Debt/Equity | 114.3 | 89.67 | 105.19 | 55.05 | 36.49 | |||||
Total Debt / Total Capital | 53.34 | 47.28 | 51.26 | 35.51 | 26.74 | |||||
LT Debt/Equity | 111.08 | 83.04 | 60.17 | 1.98 | 23.83 | |||||
Long-Term Debt / Total Capital | 51.83 | 43.78 | 29.32 | 1.28 | 17.46 | |||||
Total Liabilities / Total Assets | 67.39 | 58.28 | 63.57 | 56.56 | 56.87 | |||||
EBIT / Interest Expense | -28.94 | -41.35 | -31.95 | -30.71 | -15.07 | |||||
EBITDA / Interest Expense | -12.09 | -24.51 | -17.55 | -12.95 | 13.19 | |||||
(EBITDA - Capex) / Interest Expense | -17.64 | -30.72 | -20.58 | -14.05 | 7.97 | |||||
Total Debt / EBITDA | -6.78 | -5.11 | -3.64 | -3.71 | 4.38 | |||||
Net Debt / EBITDA | 2.98 | 2.85 | 0.81 | 3.37 | -9.81 | |||||
Total Debt / (EBITDA - Capex) | -4.65 | -4.08 | -3.1 | -3.42 | 7.24 | |||||
Net Debt / (EBITDA - Capex) | 2.04 | 2.27 | 0.69 | 3.1 | -16.23 | |||||
Growth Over Prior Year | ||||||||||
Total Revenues, 1 Yr. Growth % | 77.03 | 61.54 | 12.98 | 2.87 | 19.1 | |||||
Gross Profit, 1 Yr. Growth % | 138.62 | 42.36 | -4.79 | 41.37 | 61.23 | |||||
EBITDA, 1 Yr. Growth % | 256.81 | 180.93 | 17.37 | -50.13 | -142.11 | |||||
EBITA, 1 Yr. Growth % | 196.12 | 159.24 | 20.09 | -43.68 | -114 | |||||
EBIT, 1 Yr. Growth % | 110.07 | 104.68 | 24.69 | -36.83 | -73.46 | |||||
Earnings From Cont. Operations, 1 Yr. Growth % | 134.28 | 122.94 | 10.26 | -35.91 | -71.66 | |||||
Net Income, 1 Yr. Growth % | 133.65 | 125.43 | 10.43 | -35.68 | -72.07 | |||||
Normalized Net Income, 1 Yr. Growth % | 135.7 | 121.21 | 20.7 | -41.18 | -81.23 | |||||
Diluted EPS Before Extra, 1 Yr. Growth % | 118.3 | 105.18 | 6.26 | -38.54 | -72.29 | |||||
Accounts Receivable, 1 Yr. Growth % | 41.46 | 31.2 | -3.89 | 18.46 | -22.05 | |||||
Inventory, 1 Yr. Growth % | 127.9 | 205.88 | -6.62 | -53.12 | 22.31 | |||||
Net Property, Plant and Equip., 1 Yr. Growth % | 47.64 | 77.21 | -9.12 | -41.76 | -17.56 | |||||
Total Assets, 1 Yr. Growth % | 53.81 | 118.11 | -19.64 | -20.73 | -1.39 | |||||
Tangible Book Value, 1 Yr. Growth % | -9.94 | 293.41 | -47.29 | -1.79 | 1.78 | |||||
Common Equity, 1 Yr. Growth % | 7.77 | 185.57 | -29.79 | -5.55 | -1.97 | |||||
Cash From Operations, 1 Yr. Growth % | 287.1 | -451.48 | 47.77 | -106.82 | 2.16K | |||||
Capital Expenditures, 1 Yr. Growth % | 103.39 | 60.33 | -21.23 | -76.08 | 155.84 | |||||
Levered Free Cash Flow, 1 Yr. Growth % | -117.38 | -1.9K | -38.5 | -139.06 | 333.11 | |||||
Unlevered Free Cash Flow, 1 Yr. Growth % | -121.66 | -1.54K | -40.2 | -144.44 | 303.35 | |||||
Compound Annual Growth Rate Over Two Years | ||||||||||
Total Revenues, 2 Yr. CAGR % | 70.47 | 69.11 | 35.1 | 7.81 | 10.69 | |||||
Gross Profit, 2 Yr. CAGR % | 82.21 | 84.31 | 16.42 | 16.02 | 50.98 | |||||
EBITDA, 2 Yr. CAGR % | 305.01 | 216.6 | 81.58 | -23.49 | -55.76 | |||||
EBITA, 2 Yr. CAGR % | 206.17 | 177.07 | 76.44 | -17.76 | -72.77 | |||||
EBIT, 2 Yr. CAGR % | 107.58 | 107.36 | 59.76 | -11.25 | -59.9 | |||||
Earnings From Cont. Operations, 2 Yr. CAGR % | 120.24 | 128.54 | 56.79 | -15.93 | -57.38 | |||||
Net Income, 2 Yr. CAGR % | 121.06 | 129.5 | 57.77 | -15.72 | -57.62 | |||||
Normalized Net Income, 2 Yr. CAGR % | 138.01 | 128.34 | 63.4 | -15.74 | -67.48 | |||||
Diluted EPS Before Extra, 2 Yr. CAGR % | 81.48 | 111.64 | 47.66 | -19.19 | -58.73 | |||||
Accounts Receivable, 2 Yr. CAGR % | 80.22 | 36.23 | 12.29 | 6.7 | -3.9 | |||||
Inventory, 2 Yr. CAGR % | 62.77 | 164.03 | 69 | -33.84 | -24.28 | |||||
Net Property, Plant and Equip., 2 Yr. CAGR % | 38.91 | 61.75 | 26.91 | -27.24 | -30.71 | |||||
Total Assets, 2 Yr. CAGR % | 50.83 | 83.16 | 32.39 | -20.19 | -11.59 | |||||
Tangible Book Value, 2 Yr. CAGR % | -7.26 | 88.23 | 44 | -28.05 | -0.02 | |||||
Common Equity, 2 Yr. CAGR % | 4.57 | 75.43 | 41.6 | -18.57 | -3.78 | |||||
Cash From Operations, 2 Yr. CAGR % | 1.07 | 268.86 | 127.9 | -68.26 | 24.01 | |||||
Capital Expenditures, 2 Yr. CAGR % | 43.22 | 80.58 | 12.38 | -56.59 | -21.77 | |||||
Levered Free Cash Flow, 2 Yr. CAGR % | -36.06 | 77.07 | 233.05 | -50.99 | 24.61 | |||||
Unlevered Free Cash Flow, 2 Yr. CAGR % | -29.2 | 76.85 | 193.85 | -48.45 | 28.01 | |||||
Compound Annual Growth Rate Over Three Years | ||||||||||
Total Revenues, 3 Yr. CAGR % | 69.4 | 67.44 | 47.83 | 23.37 | 11.45 | |||||
Gross Profit, 3 Yr. CAGR % | 72.93 | 67.82 | 47.88 | 24.2 | 29.47 | |||||
EBITDA, 3 Yr. CAGR % | 160.68 | 258.51 | 127.44 | 18.03 | -37.3 | |||||
EBITA, 3 Yr. CAGR % | 247.04 | 189.65 | 109.68 | 20.58 | -54.42 | |||||
EBIT, 3 Yr. CAGR % | 141.04 | 106.61 | 75.02 | 17.26 | -40.65 | |||||
Earnings From Cont. Operations, 3 Yr. CAGR % | 74.83 | 121.14 | 79.25 | 16.36 | -41.49 | |||||
Net Income, 3 Yr. CAGR % | 74.01 | 122.5 | 79.84 | 16.99 | -41.68 | |||||
Normalized Net Income, 3 Yr. CAGR % | 155.97 | 132.27 | 84.63 | 16.24 | -48.92 | |||||
Diluted EPS Before Extra, 3 Yr. CAGR % | 2.15 | 89.06 | 68.21 | 10.24 | -43.44 | |||||
Accounts Receivable, 3 Yr. CAGR % | 38.93 | 62.12 | 21.28 | 14.31 | -3.9 | |||||
Inventory, 3 Yr. CAGR % | 162.23 | 100.86 | 86.71 | 10.22 | -18.8 | |||||
Net Property, Plant and Equip., 3 Yr. CAGR % | 59.89 | 50.65 | 33.47 | -2.11 | -24.15 | |||||
Total Assets, 3 Yr. CAGR % | 90.11 | 70.56 | 39.18 | 11.59 | -14.36 | |||||
Tangible Book Value, 3 Yr. CAGR % | 17.77 | 50.13 | 23.15 | 26.76 | -19.23 | |||||
Common Equity, 3 Yr. CAGR % | 57.66 | 46.16 | 29.28 | 23.72 | -13.37 | |||||
Cash From Operations, 3 Yr. CAGR % | 17.47 | 53.12 | 171.91 | -29.26 | 31.47 | |||||
Capital Expenditures, 3 Yr. CAGR % | 60.77 | 48.71 | 36.95 | -32.9 | -21.59 | |||||
Levered Free Cash Flow, 3 Yr. CAGR % | 0.73 | 94.65 | 24.46 | 63.03 | 1.33 | |||||
Unlevered Free Cash Flow, 3 Yr. CAGR % | 7.81 | 93.43 | 23.21 | 56.56 | 2.34 | |||||
Compound Annual Growth Rate Over Five Years | ||||||||||
Total Revenues, 5 Yr. CAGR % | 146.82 | 105.94 | 54.74 | 40.4 | 31.68 | |||||
Gross Profit, 5 Yr. CAGR % | 75.1 | 74.55 | 47.61 | 44.78 | 49.11 | |||||
EBITDA, 5 Yr. CAGR % | 34.15 | 40.31 | 125.57 | 93.28 | 19.83 | |||||
EBITA, 5 Yr. CAGR % | 39.34 | 43.18 | 164.77 | 75.05 | -6.19 | |||||
EBIT, 5 Yr. CAGR % | 53.47 | 48.35 | 104.48 | 47.35 | -2.11 | |||||
Earnings From Cont. Operations, 5 Yr. CAGR % | 39.85 | 41.83 | 67.37 | 50.19 | 0.91 | |||||
Net Income, 5 Yr. CAGR % | 39.55 | 41.78 | 67.33 | 50.9 | 0.88 | |||||
Normalized Net Income, 5 Yr. CAGR % | 51.46 | 48.25 | 113.91 | 54.83 | -7.02 | |||||
Diluted EPS Before Extra, 5 Yr. CAGR % | -2.17 | -2.63 | 18.37 | 34.57 | -4.12 | |||||
Accounts Receivable, 5 Yr. CAGR % | 129.25 | 65.7 | 27.59 | 37.15 | 10.5 | |||||
Inventory, 5 Yr. CAGR % | 175.99 | 141.56 | 119.97 | 28.82 | 30.14 | |||||
Net Property, Plant and Equip., 5 Yr. CAGR % | 86 | 92.54 | 45.77 | 12.6 | 2.69 | |||||
Total Assets, 5 Yr. CAGR % | 83.19 | 88.86 | 64.49 | 25.88 | 16.08 | |||||
Tangible Book Value, 5 Yr. CAGR % | 43.28 | 56.45 | 27.63 | 11.86 | 13.3 | |||||
Common Equity, 5 Yr. CAGR % | 69.44 | 74.97 | 51.02 | 15.67 | 14.88 | |||||
Cash From Operations, 5 Yr. CAGR % | 31.44 | 67.8 | 53.13 | -18.41 | 98.63 | |||||
Capital Expenditures, 5 Yr. CAGR % | 87.91 | 87.01 | 39.31 | -9.13 | 9.47 | |||||
Levered Free Cash Flow, 5 Yr. CAGR % | - | 85.73 | 62.51 | 12.12 | 26.68 | |||||
Unlevered Free Cash Flow, 5 Yr. CAGR % | - | 85.03 | 61 | 13.98 | 27.37 |
- Stock Market
- Equities
- BILI Stock
- Financials Bilibili Inc.
- Financial Ratios
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition















